Granted I was only 15 at the time, however Affymax was already acquired once. Then spun-off, left for dead in a standalone IPO, then forced to survive. Well, fast forward 17 years later, Affymax survived and seems to be thriving.
I just believe history will eventually repeat itself:
Article from 1995:
PALO ALTO - Affymax N.V. has signed an agreement to be purchased by one of the largest pharmaceutical companies in the world for $533 million, marking the latest merger in the consolidating drug industry.
London-based giant Glaxo PLC agreed to buy Affymax, which is headquartered in Amsterdam but conducts all its research and development in Palo Alto and Santa Clara, for $30 per share - a 66 percent premium over Affymax's closing price of 18 on the Nasdaq exchange Wednesday. On the news of the acquisition, Affymax' share price on Thursday jumped to 29-1/4.